126.61
price down icon0.45%   -0.57
after-market Handel nachbörslich: 126.61
loading
Schlusskurs vom Vortag:
$127.18
Offen:
$126.97
24-Stunden-Volumen:
4.72M
Relative Volume:
0.82
Marktkapitalisierung:
$220.36B
Einnahmen:
$43.84B
Nettoeinkommen (Verlust:
$13.94B
KGV:
15.83
EPS:
7.9979
Netto-Cashflow:
$6.78B
1W Leistung:
-0.73%
1M Leistung:
-5.20%
6M Leistung:
-2.25%
1J Leistung:
+10.99%
1-Tages-Spanne:
Value
$126.19
$128.45
1-Wochen-Bereich:
Value
$125.00
$128.94
52-Wochen-Spanne:
Value
$110.86
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Firmenname
Abbott Laboratories
Name
Telefon
(224) 667-6100
Name
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Mitarbeiter
114,000
Name
Twitter
@AbbottNews
Name
Nächster Verdiensttermin
2025-10-15
Name
Neueste SEC-Einreichungen
Name
ABT's Discussions on Twitter

Vergleichen Sie ABT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
ABT
Abbott Laboratories
126.61 221.35B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
100.97 151.78B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
375.93 146.70B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
93.23 120.73B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.19 47.45B 5.69B 1.41B 577.90M 6.9828

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-10 Eingeleitet The Benchmark Company Buy
2025-07-18 Hochstufung Jefferies Hold → Buy
2025-06-16 Eingeleitet Leerink Partners Market Perform
2024-10-08 Eingeleitet Oppenheimer Outperform
2024-09-19 Eingeleitet Piper Sandler Overweight
2024-07-30 Herabstufung Edward Jones Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2023-07-21 Hochstufung Wolfe Research Underperform → Peer Perform
2023-05-30 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-04-20 Bestätigt Barclays Overweight
2023-04-20 Bestätigt Bernstein Outperform
2023-04-20 Bestätigt JP Morgan Overweight
2023-04-20 Bestätigt Raymond James Outperform
2023-04-20 Bestätigt UBS Buy
2023-04-20 Bestätigt Wolfe Research Underperform
2023-03-29 Eingeleitet UBS Buy
2022-10-26 Eingeleitet Mizuho Neutral
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Hold
2022-07-06 Eingeleitet Wolfe Research Underperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-01-27 Bestätigt Credit Suisse Outperform
2022-01-27 Bestätigt Morgan Stanley Overweight
2022-01-27 Bestätigt Raymond James Outperform
2022-01-27 Bestätigt UBS Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-10-27 Hochstufung Atlantic Equities Neutral → Overweight
2021-10-14 Eingeleitet Redburn Neutral
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Neutral
2021-01-28 Hochstufung BTIG Research Neutral → Buy
2020-09-11 Eingeleitet Wolfe Research Outperform
2020-06-01 Herabstufung Goldman Neutral → Sell
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Neutral
2020-01-02 Herabstufung Guggenheim Buy → Neutral
2019-06-13 Bestätigt BofA/Merrill Buy
2019-02-07 Bestätigt BofA/Merrill Buy
2019-01-02 Herabstufung Citigroup Neutral → Sell
2018-11-30 Hochstufung Goldman Neutral → Buy
2018-10-16 Eingeleitet Barclays Overweight
2018-06-27 Eingeleitet Bernstein Outperform
2018-01-30 Bestätigt Citigroup Neutral
2018-01-25 Bestätigt Stifel Buy
2018-01-25 Hochstufung William Blair Mkt Perform → Outperform
2018-01-03 Eingeleitet Evercore ISI Outperform
2018-01-02 Hochstufung JP Morgan Neutral → Overweight
2018-01-02 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-10-19 Bestätigt RBC Capital Mkts Outperform
2017-10-19 Bestätigt Stifel Buy
Alle ansehen

Abbott Laboratories Aktie (ABT) Neueste Nachrichten

pulisher
08:59 AM

Data supports Abbott Tendyne mitral valve replacement - MassDevice

08:59 AM
pulisher
06:26 AM

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? - The Motley Fool

06:26 AM
pulisher
12:38 PM

Technical signs of recovery in Abbott LaboratoriesMarket Volume Summary & Target Return Focused Stock Picks - newser.com

12:38 PM
pulisher
Oct 27, 2025

Abbott Laboratories, facing hundreds of lawsuits over safety of formula for premature babies, notches a win in federal court - Slipcase

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott’s New Study on Dydrogesterone: A Potential Game-Changer for Endometriosis Pain - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Abbott Laboratories (Common Stock) (ABL0) stock a buy for dividend portfoliosJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories wins Illinois court case on NEC baby formula claims - Global Food Industry News

Oct 27, 2025
pulisher
Oct 27, 2025

Using R and stats models for Abbott Laboratories forecastingWeekly Market Summary & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What is the fair value estimate for Abbott Laboratories (ABL) stock in 2025Trade Risk Report & Smart Swing Trading Techniques - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in Abbott Laboratories offer an exitSwing Trade & High Conviction Investment Ideas - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Is Abbott Laboratories stock a buy in volatile marketsGap Up & Verified Stock Trade Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum - MSN

Oct 26, 2025
pulisher
Oct 26, 2025

Will Abbott Laboratories (ABL) stock maintain strong growthStop Loss & Verified Momentum Stock Watchlist - newser.com

Oct 26, 2025
pulisher
Oct 24, 2025

Abbott Laboratories wins lawsuit over safety of baby formula - Chicago Tribune

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether as Judge Rules Human-Milk Alternative ‘Unfeasible’ - USA Herald

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether In Cow Milk Baby Formula MDL - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott wins third of four 'bellwether' infant formula lawsuits - Crain's Chicago Business

Oct 24, 2025
pulisher
Oct 24, 2025

Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott - openPR.com

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Can't Expand Glucose Monitor Sales Ban At UPC - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Meet RFK’s Corporate Underlings - The American Prospect

Oct 24, 2025
pulisher
Oct 23, 2025

Is Abbott Laboratories stock dividend growth reliableJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How Abbott’s Innovative Partnerships Are Shaping Its 2025 Valuation Amid 12.8% YTD Gain - simplywall.st

Oct 23, 2025
pulisher
Oct 23, 2025

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - GlobeNewswire

Oct 23, 2025
pulisher
Oct 23, 2025

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question - The Globe and Mail

Oct 23, 2025
pulisher
Oct 22, 2025

Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

A Look Into Abbott Laboratories Inc's Price Over Earnings - Sahm

Oct 22, 2025
pulisher
Oct 22, 2025

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

How Abbott Laboratories stock compares to growth peersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Abbott Laboratories (Common Stock) (ABL0) stock sustain margin levelsGap Down & Entry and Exit Point Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories (ABL) stock cheap by valuation metricsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories showing signs of accumulationMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Volatility clustering patterns for Abbott LaboratoriesPortfolio Risk Report & Real-Time Market Trend Scan - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to sell Abbott's CGM in US 1st - Fierce Biotech

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott - Boston Athletic Association

Oct 21, 2025
pulisher
Oct 21, 2025

Daiwa Securities Adjusts Abbott Laboratories Price Target to $136 From $134, Maintains Outperform Rating - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor - Reuters

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart (WMT) Expands Health Offerings with Abbott's Lingo Gluco - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart said to become first physical retailer to sell Abbott’s OTC glucose monitor, Lingo - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

How to read the order book for Abbott Laboratories2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test - NeurologyLive

Oct 21, 2025
pulisher
Oct 21, 2025

Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 20, 2025

Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Will Abbott Laboratories price bounce be sustainableTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why analysts recommend Abbott Laboratories (ABL) stockPortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Abbott Laboratories (ABL) stock a safe buy pre earningsTrade Exit Report & Weekly Top Gainers Trade List - Trung tâm Dự báo KTTV quốc gia

Oct 20, 2025
pulisher
Oct 20, 2025

Lobbying Update: $1,128,989 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative

Oct 20, 2025

Finanzdaten der Abbott Laboratories-Aktie (ABT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices BSX
$100.97
price down icon 1.43%
medical_devices SYK
$375.93
price down icon 2.03%
medical_devices MDT
$93.23
price down icon 0.96%
medical_devices EW
$82.19
price up icon 1.70%
$79.40
price up icon 1.34%
Kapitalisierung:     |  Volumen (24h):